SCHEMBL32688412

SCHEMBL32688412

CC(=O)N1CCN(c2cccc(C(=O)O)c2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.69
KDM4E B2RXH2 2/20 0.69
MEN1 O00255 2/20 0.69
ALDH1A1 P00352 2/20 0.69
GAA P10253 2/20 0.69
KMT2A Q03164 2/20 0.69
HPGD P15428 1/20 0.69
KMO O15229 1/20 0.63
TTR P02766 1/20 0.56
USP2 O75604 3/20 0.56
MAPK1 P28482 2/20 0.56
MAPT P10636 2/20 0.56
LMNA P02545 1/20 0.56
TSHR P16473 1/20 0.56
ENPP2 Q13822 7/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 1/20 0.55
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2322269 0.89 MAPT (0.54) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL28685766 0.87 ALDH1A1 (0.73) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL32688379 0.85 ALDH1A1 (0.80) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL3319386 0.84 ALDH1A1 (0.73) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL29631156 0.84 ALDH1A1 (0.73) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL21858310 0.84 KDM4E (0.53) KDM4EMEN1ALDH1A1GAAKMT2A
SCHEMBL1517203 0.82 ALDH1A1 (1.00) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL29717077 0.82 ALDH1A1 (1.00) HSD17B10KDM4EMEN1ALDH1A1GAA
SCHEMBL4670098 0.81 USP2 (0.72) HSD17B10MEN1ALDH1A1GAAKMT2A
SCHEMBL8230032 0.81 ALDH1A1 (0.61) HSD17B10ALDH1A1GAAHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD17B10 30/4885KDM4E 3207/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.